Assembly Biosciences, Inc. (ASMB) vs Bright Minds Biosciences Inc. (DRUG)

A side-by-side comparison of Assembly Biosciences, Inc. and Bright Minds Biosciences Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ASMB vs DRUG

growth of $100 · dividends reinvested · last 6y
ASMB -59.6% (-14.0%/yr)DRUG +84.4% (+10.7%/yr)DRUG compounded faster over this window
0100200300Start $10020222023202420252026$40$184
ASMB DRUG

ASMB vs DRUG: by the numbers

  • •DRUG is the larger company ($472M vs $434M market cap).

Metrics side by side

Valuation

MetricASMBDRUG
P/E ratio39.86N/A
P/S ratio5.81N/A
P/B ratio1.422.18

Profitability

MetricASMBDRUG
Gross margin99.82%0.00%
Operating margin-11.75%0.00%
Net margin-0.06%0.00%
ROE-0.01%-8.21%
ROIC-2.86%-13.15%

Growth (annualized)

MetricASMBDRUG
Revenue CAGR (5Y)-1.78%N/A
Total return CAGR (5Y)-10.66%6.76%

Frequently asked

How have ASMB and DRUG total returns compared?
Over the past 5 years, ASMB delivered -10.66% and DRUG delivered 6.76% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.